论文部分内容阅读
我院儿科门诊于1985年8～9月病毒性上呼吸道感染流行期间,采用SIgA治疗婴幼儿患者51例,取得较满意疗效.报告如下。临床资料:治疗组51例,男32例,女19例;对照组45例,男35例,女10例。二组年龄均在3岁以下。病程在48小时内,有发热。白细胞总数均在10×10~9/L以下,中性粒细胞正常。治疗:治疗组单给予SIgA,每天0.3～0.5mg/kg,分6～8次滴鼻,连滴3天。对照组予溶菌酶,
Pediatric clinic in our hospital from August to September 1985 during the epidemic of viral upper respiratory infection, the use of SIgA treatment of infants and young children in 51 cases, achieved more satisfactory results. Clinical data: The treatment group 51 cases, 32 males and 19 females; control group 45 cases, 35 males and 10 females. Both groups are under 3 years of age. Course of fever in 48 hours. The total number of white blood cells in 10 × 10 ~ 9 / L below the normal neutrophils. Treatment: single treatment group given SIgA, 0.3 ~ 0.5mg / kg daily, 6 to 8 drops of nasal drops, and even drop 3 days. The control group to lysozyme,